Assembly Biosciences stockholders approve 1.2M share increase to equity compensation plan

Filed June 5, 2026 · Period ending June 4, 2026 · ~1 min read

Key Changes

• medium

  Stockholders approved adding 1.2 million shares to the 2018 Stock Incentive Plan, increasing total reserved shares from 1.48 million to 2.68 million for employee equity grants and stock-based compensation.

  Item 5.07 verify on EDGAR →
• low

  Employee Stock Purchase Plan expanded by 290,000 shares to 515,000 total, allowing increased employee participation but representing additional potential dilution to existing shareholders.

  Item 5.07 verify on EDGAR →
• low

  Nine directors elected to serve until 2027 annual meeting, all receiving overwhelming stockholder support with over 11 million votes each and minimal opposition.

  Item 5.07 verify on EDGAR →